Latest news
Emergent BioSolutions laying off dozens, shedding real estate as Narcan competition strains profits - The Business JournalsThe Business Journals · Thu, 06 Aug 2026 19:25:00 GMTEmergent BioSolutions Inc (EBS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Thu, 06 Aug 2026 07:00:00 GMTVanguard Capital Management (EBS) discloses 4.92% Emergent BioSolutions ownership - Stock TitanStock Titan · Fri, 31 Jul 2026 07:00:00 GMTLandmark Bio, Syngoi Now to Operate Under Artis BioSolutions Name - Contract PharmaContract Pharma · Wed, 29 Jul 2026 17:49:34 GMT